Taken together, these data showed that CD3+ T cells as well as CD19+IgD+ B cells exhibiting effector phenotypes were remarkably decreased in the ADM and metastatic tumor stages, playing an immunoactive role, while immunosuppressive Tregs exclusively accumulated in the ADM pancreas. This evidence concerns the gene CD19 and metastatic neoplasm.